Lone Korean biotech nears $81m antiaging prize
PRGS&Tech is South Korea’s only team left in XPRIZE Healthspan’s $110 million race to prove a drug can help everyone age more slowly. Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Tec
<p>PRGS&Tech is South Korea’s only team left in XPRIZE Healthspan’s $110 million race to prove a drug can help everyone age more slowly. Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Tec</p>